Redeye is not surprised by the high subscription rate, considering the share has traded above the strike price. The amount received should cover the company until reaching a positive cash flow.

Läs mer på Redeye

Ämnen i artikeln


Oncopeptides

Senast

1,30

1 dag %

−1,89%

1 dag

1 mån

1 år

Marknadsöversikt

1 DAG %

Senast

1 mån